Phenylpropanolamine and other over-the-counter vasoactive compounds

Hypertension

Volumn 11, Issue 3, 1988, Pages II.7-II.10

  Bravo, Emmanuel L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Hypertension; Over the counter drugs; Phenylpropanolamine; vasoactive compounds

Indexed keywords

ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; NON PRESCRIPTION DRUG; PHENYLPROPANOLAMINE;

BLOOD PRESSURE; HUMAN; HYPERTENSION; PRIORITY JOURNAL; SHORT SURVEY; VASCULAR RESISTANCE;

CHEMISTRY; DRUGS, NON-PRESCRIPTION; HUMAN; HYPERTENSION; PHENYLPROPANOLAMINE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0023889313     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.hyp.11.3_pt_2.ii7     Document Type: Article

References (20)

1. Bernstein E, Distant B. Phenylpropanolamine: a potentially hazardous drug. Ann Eroerg Med 1982;11:311-315
2. Horowitz JD, Lang WJ, Howes LG, et al. Hypertensive response induced by phenylpropanolamine in anorectic and decongestaqt preparation's. Lancet 1980; 1:60-61.
3. Horowitz JD, McNiel JJ, Sweet B, Mendelsohn FAO, Louis WJ. Hypertension and postural hypotension induced by phenylpropanolamine (tfimolets). Med J Aust 1979; 1:1975-1976
4. Mueller SM, Solow EB. Seizures associated with a new combination “pick-me-up“ pill. Ann Neural 1982;11:322
5. Novenuis G, Widerlov E, Lonnerholm G. Phenylpropanolamine, and mental disturbance. Lancet 1979 2:1367-1368
6. Schaffer CB, Pauli MW: Psychotic reaction caused by proprietary oral diet agents, Am J. Psychiatry 1980; 137:1256-1257
7. Weesner KM, Denison M, Roberts RJ. Cardiac arrhythmias in an adolescent following ingestion of an over-the-counter'stimulant. Clin Pediatr (Phila)> 1982 1:700-701
8. Pentel PR, Mikell FL, Zavorol JH. Myocardial injury after ' phenylpropanolamine ingestion. Br Heart J 1982;47:51-54
9. Johnson DA, Etter HS, Reeves DM. Stroke and phenylpropanolamine [Letter]. Lancet 19832:970.
10. King J. Hypertension and cerebral hemorrhage after trimolets infection [Letter]. Med J Aust 1979;2:258.
11. Weiner N. Nbrepinephrine/epinephrirje, and the sympathomimetic amines. In: Gilman AG, Goodman'LS, Gilman A, eds. The pharmacologic basis of therapeutics. New York: Macmillan-Publishing, 1980:138-175
12. Nickerson M, Nomagochi G. Responses to sympathomimetic amines after dibenamine blockade. J Pharmacol Exp Ther 1953;107:284-299
13. GreinerTH, Garb S. The influence of drugs on the irritability aqd automaticity of heart muscle. J Pharmacol Exp Ther 1950,98:215-223
14. Treqdelenberg U, de La Sierra BGA, Muskus R. Modification by reserpine of the response of the atrial pacemaker to sympathomimetic amines. J Pharmacol Exp Ther 1963;141:301-309
15. Pentel PR, Asinger RW, Benowitz NL. Propranolol antagonism of phenylpropanolamine-induced hypertension. Clin Pharmacol Ther 1985;37:488-494
16. Goodman RP, Wright JT, Barlascini CO, McKenney JM, Lambert CM. Phenylpropanolamine and ambulatory blood pressure [Abstract]. Clin Pharmacol Ther 1986;39,:195
17. CuthberfMF, Greenberg MP, Mortey SW. Cough and cold remedies: a potential danger to patients on monoamine oxidase inhibitors. Br Med J 1969; 1:404-406
18. Lee KY, Bielin LJ, Vandongen R. Severe hypertension after ingestion of an appetite suppressant (phenylpropanolamine) with indomethacin. Lancet 1979;1:1110-1111
19. McLaren EH. Severe hypertension produced by interaction of phenylpropanolamine with methyldopa and oxprenolol. Br Med J 1976;II.:283-284
20. Dietz AJ. Amphetamine-like reactions to phenylpropanolamine. JAMA 1983;245:601-602